FIELD: biochemistry.
SUBSTANCE: group of inventions relates to methods for preventing formation, as well as destruction or eradication of biofilms of gram-positive bacteria. Disclosed are a method of preventing, destroying or eradication of a biofilm containing one or more Staphylococcus and Streptococcus bacteria, and a method of preventing or treating an infection associated with biofilm in a subject, including one or more Staphylococcus and Streptococcus bacteria. Methods involve contacting the biofilm with a composition comprising an altered lytic enzyme comprising a SH-3 PlySs2 domain comprising the amino acid sequence SEQ ID NO: 4 or a version thereof, having at least 80 % identity with SEQ ID NO: 4 and effective for binding Staphylococcus and Streptococcus in biofilm, and a catalytic domain which is a CHAP domain of lysine of streptococcal or staphylococcus phages.
EFFECT: inventions allow eliminating not only mature biofilms, but also preventing de novo biofilm formation on the surface of devices, implants and separation membranes.
26 cl, 21 dwg, 7 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
BIOFILM PREVENTION, DESTRUCTION AND TREATMENT BY BACTERIOPHAGE LYSIN | 2013 |
|
RU2646102C2 |
COMBINATIONS OF BACTERIOPHAGE LYSINE AND ANTIBIOTICS AGAINST GRAM-POSITIVE BACTERIA | 2013 |
|
RU2659208C2 |
METHOD FOR MICRO-DILUTION IN LIQUID MEDIUM FOR EVALUATING AND DETERMINING MINIMUM INHIBITORY CONCENTRATION OF ANTIBACTERIAL POLYPEPTIDES | 2017 |
|
RU2754667C2 |
BACTERIOPHAGE-DERIVED ANTIMICROBIAL POLYPEPTIDES AND THEIR USE AGAINST GRAM-NEGATIVE BACTERIA | 2019 |
|
RU2804774C2 |
LYSINE POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA | 2016 |
|
RU2724545C2 |
STRAIN OF BACTERIOPHAGE Staphylococcus aureus SA20 ENSURING DESTRUCTION OF BIOFILMS CREATED BY BACTERIA OF Staphylococcus FAMILY | 2014 |
|
RU2565824C1 |
NUCLEOTIDE SEQUENCE ENCODING β-N-ACETYLHEXOZAAMINIDASE AGGREGATIBACTER ACTINOMYCETEMCOMITANS AND GENETIC STRUCTURES CONTAINING IT | 2021 |
|
RU2789544C1 |
CONJUGATES OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS WITH RIFAMYCIN AND USE THEREOF | 2015 |
|
RU2731055C2 |
ACINETOBACTER LYSINES | 2015 |
|
RU2725809C2 |
COMBINED THERAPIES | 2016 |
|
RU2725800C2 |
Authors
Dates
2020-10-28—Published
2013-05-09—Filed